FIM
MYGN icon

Freedom Investment Management’s Myriad Genetics MYGN Stock Holding History

Freedom Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,676
Closed -$388K – 883
2021
Q2 		$388K Buy
12,676
+116
+0.9% +$3.35K 0.03% 619
2021
Q1 		$382K Sell
12,560
-2,294
-15% -$65.1K 0.03% 608
2020
Q4 		$294K Buy
14,854
+2,668
+22% +$43.1K 0.03% 478
2020
Q3 		$159K Buy
12,186
+150
+1% +$1.9K 0.02% 514
2020
Q2 		$136K Sell
12,036
-2,248
-16% -$31.9K 0.01% 530
2020
Q1 		$300K Sell
14,284
-304
-2% -$6.42K 0.03% 497
2019
Q4 		$397K Sell
14,588
-3,308
-18% -$91K 0.04% 400
2019
Q3 		$512K Buy
17,896
+1,948
+12% +$56.8K 0.04% 351
2019
Q2 		$443K Sell
15,948
-13,660
-46% -$386K 0.04% 392
2019
Q1 		$983K Buy
29,608
+4,156
+16% +$127K 0.08% 240
2018
Q4 		$740K Sell
25,452
-10,217
-29% -$368K 0.06% 327
2018
Q3 		$1.8M Sell
35,669
-1,734
-5% -$77.1K 0.11% 176
2018
Q2 		$1.4M Buy
37,403
+10,313
+38% +$348K 0.08% 254
2018
Q1 		$801K Buy
27,090
+1,083
+4% +$36.6K 0.04% 436
2017
Q4 		$893K Sell
26,007
-214
-0.8% -$7.22K 0.05% 403
2017
Q3 		$949K Sell
26,221
-11,084
-30% -$316K 0.05% 356
2017
Q2 		$964K Buy
37,305
+2,196
+6% +$46.6K 0.05% 324
2017
Q1 		$674K Buy
35,109
+18,904
+117% +$335K 0.04% 432
2016
Q4 		$270K Buy
16,205
+743
+5% +$13.4K 0.02% 737
2016
Q3 		$318K Sell
15,462
-2
-0% -$51 0.02% 611
2016
Q2 		$473K Buy
15,464
+398
+3% +$13.8K 0.03% 429
2016
Q1 		$564K Sell
15,066
-3,257
-18% -$123K 0.04% 361
2015
Q4 		$791K Sell
18,323
-9,898
-35% -$418K 0.06% 263
2015
Q3 		$338K Buy
28,221
+14,229
+102% +$505K 0.03% 436
2015
Q2 		$476K Buy
13,992
+246
+2% +$8.37K 0.05% 354
2015
Q1 		$487K Buy
13,746
+2,533
+23% +$90.7K 0.05% 314
2014
Q4 		$382K Buy
11,213
+949
+9% +$33.7K 0.05% 346
2014
Q3 		$396K Buy
10,264
+308
+3% +$11.5K 0.07% 275
2014
Q2 		$387K Buy
9,956
+209
+2% +$7.78K 0.07% 282
2014
Q1 		$333K Buy
+9,747
New +$302K 0.07% 270
2013
Q3 		– Sell
-18,149
Closed -$488K – 399
2013
Q2 		$488K Buy
+18,149
New +$526K 0.17% 106

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Freedom Investment Management's MYGN Position: Q3 2021 in Review

Freedom Investment Management sold out of Myriad Genetics (MYGN) in Q3 2021, closing a stake of 12,676 shares — an estimated $388K sold.

Freedom Investment Management first reported a position in MYGN in Q2 2013 and held it in 31 quarters. The position peaked at $1.8M in Q3 2018. 213 funds tracked by Wall St. Rank hold MYGN as of Q3 2021.

  • Freedom Investment Management reported no remaining Myriad Genetics position as of Q3 2021 after selling out during the quarter.
  • Freedom Investment Management sold 12,676 Myriad Genetics shares in Q3 2021, an estimated $388K.
  • Freedom Investment Management first reported a position in Myriad Genetics in Q2 2013 and held it in 31 quarters.
  • Freedom Investment Management's Myriad Genetics position peaked at $1.8M in Q3 2018.
  • 213 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2021.

Based on Freedom Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.